Pharmaceuticals

This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.

News | Antiplatelet and Anticoagulation Therapies

November 14, 2016 — Two differing blood clot prevention medications are just as safe and effective for patients ...

Home November 14, 2016
Home
Technology | Antiplatelet and Anticoagulation Therapies

October 28, 2016 — Medicure Inc. recently received U.S. Food and Drug Administration (FDA) market clearance for its new ...

Home October 28, 2016
Home
Blog

The 2016 Nobel Prize in chemistry was recently awarded to three scientists who developed miniaturized machines that are ...

Home October 07, 2016
Home
News | Peripheral Artery Disease (PAD)

October 7, 2016 — Mercator MedSystems recently announced that 13-month data from the DANCE trial was presented during a ...

Home October 07, 2016
Home
News | Pharmaceuticals

September 26, 2016 — Nearly 2 out of 5 people with diabetes who could benefit from statin therapy to lower their risk of ...

Home September 26, 2016
Home
News | Antiplatelet and Anticoagulation Therapies

August 18, 2016 — Researchers at the Peter Munk Cardiac Centre, Toronto, and at Mayo Clinic are leading the Tailored ...

Home August 18, 2016
Home
pros and cons of new anticoagulation therapies, anticoagulants, dabigatran, Pradaxa, novel oral anticoagulants, NOACs, rivaroxaban, Xarelto, apixaban, Eliquis
Feature | Antiplatelet and Anticoagulation Therapies | Heidi Olson, Pharm.D

With the recent introduction of several novel oral anticoagulants (NOACs) on the U.S. market that have been billed by ...

Home July 26, 2016
Home
News | Heart Failure

June 30, 2016 — Researchers at Thomas Jefferson University have discovered how to enhance the effectiveness of beta ...

Home June 30, 2016
Home
News | Antiplatelet and Anticoagulation Therapies

June 24, 2016 — More than 1 in 3 atrial fibrillation (AF) patients at intermediate to high risk for stroke are treated ...

Home June 24, 2016
Home
News | Antiplatelet and Anticoagulation Therapies

May 25, 2016 — Technavio’s latest report on the U.S. anticoagulants market provides an analysis on the most important ...

Home May 25, 2016
Home
clot, coronary thrombus, antiplatelet therapt, DAPT
Feature | Antiplatelet and Anticoagulation Therapies | Marianne Pop, Pharm.D., BCPS

There were many opinions on the duration of dual antiplatelet therapy (DAPT) highlighted at the 2016 American College of ...

Home May 19, 2016
Home
Feature | Heart Valve Technology

May 16, 2016 — The largest observational study of percutaneous transfemoral transcatheter aortic valve replacement (TAVR ...

Home May 16, 2016
Home
News | Antiplatelet and Anticoagulation Therapies

May 16, 2016 – Women younger than 55 years of age who undergo percutaneous coronary intervention (PCI) for acute ...

Home May 16, 2016
Home
News | Antiplatelet and Anticoagulation Therapies

May 9, 2016 — A new study has found an increased risk of dementia in patients with atrial fibrillation (AF) that receive ...

Home May 09, 2016
Home
Subscribe Now